# Supplementation of Dual Probiotic Strains Reduced Fasting Triglyceride and Enhanced Apolipoprotein A-V Levels

> **NCT02215694** · PHASE3 · COMPLETED · sponsor: **Yonsei University** · enrollment: 128 (actual)

## Conditions studied

- Hypertriglyceridemia

## Interventions

- **DIETARY_SUPPLEMENT:** dual probiotics
- **DIETARY_SUPPLEMENT:** placebo

## Key facts

- **NCT ID:** NCT02215694
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2014-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02215694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02215694, "Supplementation of Dual Probiotic Strains Reduced Fasting Triglyceride and Enhanced Apolipoprotein A-V Levels". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02215694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*